154 related articles for article (PubMed ID: 9808483)
1. Treatment of osteopenia and osteoporosis after kidney transplantation.
Grotz WH; Rump LC; Niessen A; Schmidt-Gayk H; Reichelt A; Kirste G; Olschewski M; Schollmeyer PJ
Transplantation; 1998 Oct; 66(8):1004-8. PubMed ID: 9808483
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bone pain after kidney transplantation.
Grotz W; Rump JA; Niessen A; Schmidt-Gayk H; Schollmeyer P
Transplant Proc; 1998 Aug; 30(5):2114-6. PubMed ID: 9723410
[No Abstract] [Full Text] [Related]
4. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.
Valero MA; Loinaz C; Larrodera L; Leon M; Moreno E; Hawkins F
Calcif Tissue Int; 1995 Jul; 57(1):15-9. PubMed ID: 7671159
[TBL] [Abstract][Full Text] [Related]
7. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
8. Clodronate treatment of established bone loss in cardiac recipients: a randomized study.
Ippoliti G; Pellegrini C; Campana C; Rinaldi M; D'Armini A; Goggi C; Aiello M; Viganò M
Transplantation; 2003 Feb; 75(3):330-4. PubMed ID: 12589153
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.
El-Husseini AA; El-Agroudy AE; El-Sayed MF; Sobh MA; Ghoneim MA
Pediatr Transplant; 2004 Aug; 8(4):357-61. PubMed ID: 15265162
[TBL] [Abstract][Full Text] [Related]
10. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.
Krieg MA; Seydoux C; Sandini L; Goy JJ; Berguer DG; Thiébaud D; Burckhardt P
Osteoporos Int; 2001; 12(2):112-6. PubMed ID: 11303710
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
Niederle MB; Foeger-Samwald U; Riss P; Selberherr A; Scheuba C; Pietschmann P; Niederle B; Kerschan-Schindl K
Langenbecks Arch Surg; 2019 Sep; 404(6):681-691. PubMed ID: 31451913
[TBL] [Abstract][Full Text] [Related]
12. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
Wang AY; Tang TK; Yau YY; Lo WK
Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis after kidney transplantation: preliminary report from a single center.
Wang HH; Chang PC; Chu SH; Liu KL; Lai PC; Huang JY; Chiang YJ
Transplant Proc; 2008 Sep; 40(7):2412-3. PubMed ID: 18790251
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
[TBL] [Abstract][Full Text] [Related]
17. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
Wang SX; Li H
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
[TBL] [Abstract][Full Text] [Related]
18. Clodronic acid in the treatment of postmenopausal osteoporosis.
Tanakol R; Yarman S; Bayraktaroglu T; Boztepe H; Alagöl F
Clin Drug Investig; 2007; 27(6):419-33. PubMed ID: 17506592
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
[TBL] [Abstract][Full Text] [Related]
20. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
